|
On Wednesday, the United States Food and Drug Administration
(FDA) announced their plans for revamping the 510(k) approval program. Section
510(k) of the Food, Drug and Cosmetic Act requires medical device manufacturers
to register and notify the agency of their intent to market a device at least
90 days in advance.
According to The Wall Street Journal, the 510(k) process was
intended for devices that were similar to existing approved products. Some say
that the process has been overused and that new devices being approved aren't always
similar to current products.
The new plan claims to streamline the process of reviewing
medical devices, which the FDA says will keep patients safer while also getting
innovative products to market faster.
Prior to their latest announcement, the FDA had been
proposing stricter regulations on medical device approvals that would've
allowed them to order post-market studies of some products. Their latest plan
retreats from this idea almost entirely, causing cheers from industry groups
and jeers from consumer advocates.
Do you think this announcement is a positive thing or should
they have continued to lobby for stricter regulations?
Source: The
Wall Street Journal
|